Coenzyme F420, helping mycobacteria find a niche in humans
Coenzyme F420, helping mycobacteria find a niche in humans
批准号:
10666639
负责人:
Michael Berney
金额:
$19.8万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-07-15 至 2024-06-30
关键词:
AdoptedAerobic BacteriaAnabolismAnaerobic BacteriaAnimalsAttentionAutophagocytosisBiochemical PathwayBiochemistryBiologyBiosynthetic ProteinsC3HeB/FeJ MouseClinicalCoenzymesDiseaseDrug ToleranceEnsureEnzymesEvolutionFlavinsFlavoproteinsFoundationsGeneticGenomeGenus MycobacteriumGoalsGranulomaGrowthHost DefenseHumanHypoxiaImmune EvasionImmune systemIn VitroInfectionInternationalInterventionLesionLife StyleLinkM. tuberculosis genomeMacrophageMetabolicMetabolismModelingMorbidity - disease rateMycobacterium lepraeMycobacterium smegmatisMycobacterium tuberculosisNecrosisNiacinamideNitroimidazolesOrganOxidation-ReductionOxidative StressOxygenPathogenesisPathologyPathway interactionsPharmaceutical PreparationsPhysiologyPlayPoint MutationPredispositionProdrugsProductionProtein BiochemistryProteinsReactionResearchResearch PersonnelRoleS-AdenosylhomocysteineS-AdenosylmethionineStressStructureSystemTimeTuberculosisbiochemical toolschromophorecofactorenvironmental stressorexperienceimprovedin vitro Modelinsightknock-downlatent infectionmetabolomicsmicroorganismmortalitymouse modelmutantmycobacterialnitrosative stresspathogenprogramsstructural biologytranscriptomicstuberculosis treatment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project summary
Mycobacterium tuberculosis, the causative agent of TB, remains an important cause of morbidity and mortality
worldwide. Persistence in hypoxic conditions within granuloma is the hallmark of TB, leading to latent infection
and limiting the application of current therapies. Understanding how M. tuberculosis supports its metabolism
under hypoxic conditions, and adapts to these challenges, is key to eliminating latent TB. “Disarming” M.
tuberculosis by removing its ability to endure the stress-inducing conditions in granuloma will provide a feasible
strategy for clinical interventions against latent TB.
We will investigate the role of the coenzyme F420 in the physiology and pathogenesis of M. tuberculosis. F420 is
a deazaflavin that acts as a carrier in a wide range of hydride transfer reactions. Growing evidence points to the
wide use of this cofactor by M. tuberculosis, with its low redox potential thought to give it key roles in hypoxic
persistence. There appears to be F420-dependent mechanisms in mycobacteria that are used to protect against
oxidative and nitrosative stress, but the contribution of F420 to M. tuberculosis metabolism and persistence
remains unclear. The ultimate goal of the project is to investigate how F420 facilitates M. tuberculosis’ survival
under hypoxic conditions within granuloma, elucidating its role in persistence. We have devised an integrated
experimental approach using genetics, metabolomics, animal infection models, and protein biochemistry tools
to determine how F420 helps M. tuberculosis persist during pathogenesis. We will construct a set of conditional
knockdown strains targeting F420 biosynthesis and metabolism, and perform in vitro studies to determine how M.
tuberculosis utilizes F420 under hypoxic conditions and during re-growth after hypoxia-induced dormancy. We will
then perform infection studies in a mouse model that develops necrotic and hypoxic TB lesions to investigate
how F420 facilitates M. tuberculosis survival inside granuloma and to understand the link between F420 and
persistence. Finally, we will reveal structural insights into the biosynthesis of F420 chromophore, providing the
foundations for mechanistic and inhibition studies of this essential reaction in F420 biosynthesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The PDIM paradox of M. tuberculosis
-
批准号:10651352
-
项目类别:
-
资助金额:$50.18万
-
财政年份:2023
-
负责人:Michael Berney
-
依托单位:
Identification of new inhibitors of essential functions in M. tuberculosis by high-throughput metabolic profiling
-
批准号:10568482
-
项目类别:
-
资助金额:$65.38万
-
财政年份:2022
-
负责人:Michael Berney
-
依托单位:
Coenzyme F420, helping mycobacteria find a niche in humans
-
批准号:10528305
-
项目类别:
-
资助金额:$25.34万
-
财政年份:2022
-
负责人:Michael Berney
-
依托单位:
Eradicating persistent M. tuberculosis by synthetic lethality of terminal respiratory oxidases
-
批准号:10509390
-
项目类别:
-
资助金额:$63.1万
-
财政年份:2018
-
负责人:Michael Berney
-
依托单位:
Eradicating persistent M. tuberculosis by synthetic lethality of terminal respiratory oxidases
-
批准号:10295045
-
项目类别:
-
资助金额:$63.1万
-
财政年份:2018
-
负责人:Michael Berney
-
依托单位:
Eradicating persistent M. tuberculosis by synthetic lethality of terminal respiratory oxidases
-
批准号:10053706
-
项目类别:
-
资助金额:$63.14万
-
财政年份:2018
-
负责人:Michael Berney
-
依托单位:
Inhibition of methionine biosynthesis eliminates persistent M. tuberculosis.
-
批准号:9111579
-
项目类别:
-
资助金额:$25.05万
-
财政年份:2016
-
负责人:Michael Berney
-
依托单位:
Inhibition of methionine biosynthesis eliminates persistent M. tuberculosis.
-
批准号:9214311
-
项目类别:
-
资助金额:$20.88万
-
财政年份:2016
-
负责人:Michael Berney
-
依托单位:
海外基金